200 related articles for article (PubMed ID: 23035716)
1. Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery.
Yu Z; Brannigan JA; Moss DK; Brzozowski AM; Wilkinson AJ; Holder AA; Tate EW; Leatherbarrow RJ
J Med Chem; 2012 Oct; 55(20):8879-90. PubMed ID: 23035716
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel and ligand-efficient inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferase.
Rackham MD; Brannigan JA; Moss DK; Yu Z; Wilkinson AJ; Holder AA; Tate EW; Leatherbarrow RJ
J Med Chem; 2013 Jan; 56(1):371-5. PubMed ID: 23170970
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and in vitro evaluation of novel enantiomerically-pure sulphonamide antimalarials.
Anusha S; Sinha A; Babu Rajeev CP; Chu TT; Mathai J; Ximei H; Fuchs JE; Shivananju N; Bender A; Preiser PR; Rangappa KS; Basappa ; Chandramohanadas R
Org Biomol Chem; 2015 Nov; 13(43):10681-90. PubMed ID: 26347024
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of high affinity inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferases directed by ligand efficiency dependent lipophilicity (LELP).
Rackham MD; Brannigan JA; Rangachari K; Meister S; Wilkinson AJ; Holder AA; Leatherbarrow RJ; Tate EW
J Med Chem; 2014 Mar; 57(6):2773-88. PubMed ID: 24641010
[TBL] [Abstract][Full Text] [Related]
5. Identification of Selective Inhibitors of
Harupa A; De Las Heras L; Colmenarejo G; Lyons-Abbott S; Reers A; Caballero Hernandez I; Chung CW; Charter D; Myler PJ; Fernández-Menéndez RM; Calderón F; Palomo S; Rodríguez B; Berlanga M; Herreros-Avilés E; Staker BL; Fernández Álvaro E; Kaushansky A
J Med Chem; 2020 Jan; 63(2):591-600. PubMed ID: 31850752
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Plasmodium vivax N-myristoyltransferase inhibitors: screening, synthesis, and structural characterization of their binding mode.
Goncalves V; Brannigan JA; Whalley D; Ansell KH; Saxty B; Holder AA; Wilkinson AJ; Tate EW; Leatherbarrow RJ
J Med Chem; 2012 Apr; 55(7):3578-82. PubMed ID: 22439843
[TBL] [Abstract][Full Text] [Related]
7. N-Myristoylation as a Drug Target in Malaria: Exploring the Role of N-Myristoyltransferase Substrates in the Inhibitor Mode of Action.
Schlott AC; Holder AA; Tate EW
ACS Infect Dis; 2018 Apr; 4(4):449-457. PubMed ID: 29363940
[TBL] [Abstract][Full Text] [Related]
8. Homology modeling and molecular dynamics simulation of N-myristoyltransferase from Plasmodium falciparum: an insight into novel antimalarial drug design.
Paul P; Chowdhury A; Das Talukdar A; Choudhury MD
J Mol Model; 2015 Mar; 21(3):37. PubMed ID: 25663521
[TBL] [Abstract][Full Text] [Related]
9. Structure-Guided Identification of Resistance Breaking Antimalarial N‑Myristoyltransferase Inhibitors.
Schlott AC; Mayclin S; Reers AR; Coburn-Flynn O; Bell AS; Green J; Knuepfer E; Charter D; Bonnert R; Campo B; Burrows J; Lyons-Abbott S; Staker BL; Chung CW; Myler PJ; Fidock DA; Tate EW; Holder AA
Cell Chem Biol; 2019 Jul; 26(7):991-1000.e7. PubMed ID: 31080074
[TBL] [Abstract][Full Text] [Related]
10. Validation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approach.
Wright MH; Clough B; Rackham MD; Rangachari K; Brannigan JA; Grainger M; Moss DK; Bottrill AR; Heal WP; Broncel M; Serwa RA; Brady D; Mann DJ; Leatherbarrow RJ; Tewari R; Wilkinson AJ; Holder AA; Tate EW
Nat Chem; 2014 Feb; 6(2):112-21. PubMed ID: 24451586
[TBL] [Abstract][Full Text] [Related]
11. Exploring Subsite Selectivity within
Rodríguez-Hernández D; Fenwick MK; Zigweid R; Sankaran B; Myler PJ; Sunnerhagen P; Kaushansky A; Staker BL; Grøtli M
J Med Chem; 2024 May; 67(9):7312-7329. PubMed ID: 38680035
[No Abstract] [Full Text] [Related]
12. Synthesis and Antimalarial Activity of 1,4-Disubstituted Piperidine Derivatives.
Seck R; Gassama A; Cojean S; Cavé C
Molecules; 2020 Jan; 25(2):. PubMed ID: 31940857
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria.
Hoelz LV; Calil FA; Nonato MC; Pinheiro LC; Boechat N
Future Med Chem; 2018 Aug; 10(15):1853-1874. PubMed ID: 30019917
[TBL] [Abstract][Full Text] [Related]
14. 1-Azaaurones derived from the naturally occurring aurones as potential antimalarial drugs.
Souard F; Okombi S; Beney C; Chevalley S; Valentin A; Boumendjel A
Bioorg Med Chem; 2010 Aug; 18(15):5724-31. PubMed ID: 20630767
[TBL] [Abstract][Full Text] [Related]
15. Acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase.
Nguyen C; Ruda GF; Schipani A; Kasinathan G; Leal I; Musso-Buendia A; Kaiser M; Brun R; Ruiz-Pérez LM; Sahlberg BL; Johansson NG; Gonzalez-Pacanowska D; Gilbert IH
J Med Chem; 2006 Jul; 49(14):4183-95. PubMed ID: 16821778
[TBL] [Abstract][Full Text] [Related]
16. Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues.
Vallone A; D'Alessandro S; Brogi S; Brindisi M; Chemi G; Alfano G; Lamponi S; Lee SG; Jez JM; Koolen KJM; Dechering KJ; Saponara S; Fusi F; Gorelli B; Taramelli D; Parapini S; Caldelari R; Campiani G; Gemma S; Butini S
Eur J Med Chem; 2018 Apr; 150():698-718. PubMed ID: 29571157
[TBL] [Abstract][Full Text] [Related]
17. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
[TBL] [Abstract][Full Text] [Related]
18. Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarials.
Bendale P; Olepu S; Suryadevara PK; Bulbule V; Rivas K; Nallan L; Smart B; Yokoyama K; Ankala S; Pendyala PR; Floyd D; Lombardo LJ; Williams DK; Buckner FS; Chakrabarti D; Verlinde CL; Van Voorhis WC; Gelb MH
J Med Chem; 2007 Sep; 50(19):4585-605. PubMed ID: 17722901
[TBL] [Abstract][Full Text] [Related]
19. Homology modeling and molecular dynamics simulation of N-myristoyltransferase from protozoan parasites: active site characterization and insights into rational inhibitor design.
Sheng C; Ji H; Miao Z; Che X; Yao J; Wang W; Dong G; Guo W; Lü J; Zhang W
J Comput Aided Mol Des; 2009 Jun; 23(6):375-89. PubMed ID: 19370313
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 2.
Ebiike H; Masubuchi M; Liu P; Kawasaki K; Morikami K; Sogabe S; Hayase M; Fujii T; Sakata K; Shindoh H; Shiratori Y; Aoki Y; Ohtsuka T; Shimma N
Bioorg Med Chem Lett; 2002 Feb; 12(4):607-10. PubMed ID: 11844682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
